Literature DB >> 23325043

The post-thrombotic syndrome: a 2012 therapeutic update.

Jean-Philippe Galanaud1, Susan R Kahn.   

Abstract

OPINION STATEMENT: Post-thrombotic syndrome (PTS) refers to chronic manifestations of venous insufficiency following a deep-vein thrombosis (DVT). It is a frequent, chronic, burdensome and costly disease for which therapeutic options are limited. Above all, the optimal management of PTS consists of preventing its occurrence: first, by preventing DVT, and second, by preventing development of PTS after a DVT. Prevention of DVT is challenging, particularly in the case of nonsurgical hospital inpatients, where physician's adherence to recommended thromboprophylaxis is often low. In our opinion, this adherence should be improved by generalizing the use of multi-component approaches, including that of automatic reminders. For prevention of PTS after an acute DVT, our recommendations are as follows. After a proximal (popliteal and above) DVT we recommend early ambulation with daily use of 30-40 mmHg graduated elastic compression stockings (ECS) for two years, in addition to careful monitoring of anticoagulant therapy. Below-knee ECS are preferred to thigh-length ECS, as they have similar efficacy in preventing PTS and are better tolerated. To improve compliance with ECS, patient education is important, and use of lighter strengths of compression in patients not tolerating traditional strengths should be considered. Catheter-directed thrombolysis of acute DVT was recently shown to be effective in preventing PTS, but we believe that confirmatory studies are needed before recommending its general use. The cornerstone of management of established PTS relies on patient education and use of compression therapy. We encourage ambulation, use of ECS to manage symptoms, and participation in an exercise training program, which has the potential to improve patients' quality of life (QOL) and PTS scores. In the absence of symptom relief, ECS that provide a higher strength (40-50 mmHg) should be tried. In case of moderate to severe PTS, intermittent compressive devices can be used to improve PTS symptoms. Surgery and endovascular procedures, including balloon angioplasty, stent placement, endovenectomy or valve reconstruction should be considered only in specialized centers, and only for patients with severe PTS for whom previous conservative treatment has failed. These techniques are still under evaluation and the level of evidence supporting their use is low.

Entities:  

Year:  2013        PMID: 23325043     DOI: 10.1007/s11936-012-0224-3

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  41 in total

Review 1.  Definition of post-thrombotic syndrome following lower extremity deep venous thrombosis and standardization of outcome measurement in pediatric clinical investigations.

Authors:  N A Goldenberg; L R Brandão; J Journeycake; S R Kahn; P Monagle; S Revel-vilk; A Sharathkumar; A K C Chan
Journal:  J Thromb Haemost       Date:  2012-03       Impact factor: 5.824

2.  Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins?

Authors:  T Baglin
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

3.  Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome.

Authors:  A C Bouman; J J M Smits; H Ten Cate; A J Ten Cate-Hoek
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

Review 4.  Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; John W Eikelboom; Michael K Gould; David A Garcia; Mark Crowther; M Hassan Murad; Susan R Kahn; Yngve Falck-Ytter; Charles W Francis; Maarten G Lansberg; Elie A Akl; Jack Hirsh
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 5.  Pharmacologic and compression therapies for postthrombotic syndrome: a systematic review of randomized controlled trials.

Authors:  Jacqueline M Cohen; Elie A Akl; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

6.  Nine years' experience with heparin in acute venous thrombosis.

Authors:  G BAUER
Journal:  Angiology       Date:  1950-04       Impact factor: 3.619

7.  Individually tailored duration of elastic compression therapy in relation to incidence of the postthrombotic syndrome.

Authors:  Arina J Ten Cate-Hoek; Hugo Ten Cate; Jan Tordoir; Karly Hamulyák; Martin H Prins
Journal:  J Vasc Surg       Date:  2010-04-10       Impact factor: 4.268

8.  Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency.

Authors:  J P Galanaud; C A Holcroft; M A Rodger; M J Kovacs; M T Betancourt; P S Wells; D R Anderson; I Chagnon; G Le Gal; S Solymoss; M A Crowther; A Perrier; R H White; L M Vickars; T Ramsay; S R Kahn
Journal:  J Thromb Haemost       Date:  2013-03       Impact factor: 5.824

Review 9.  Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review.

Authors:  Russell D Hull; Jane Liang; Grace Townshend
Journal:  Am J Med       Date:  2011-08       Impact factor: 4.965

10.  Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE.

Authors:  M Andrew; M David; M Adams; K Ali; R Anderson; D Barnard; M Bernstein; L Brisson; B Cairney; D DeSai
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

View more
  3 in total

1.  Gastrointestinal Malignancies and Venous Thromboembolic Disease: Clinical Significance and Endovascular Interventions.

Authors:  Xin Li; Sasan Partovi; Sameer Gadani; Charles Martin; Avi Beck; Suresh Vedantham
Journal:  Dig Dis Interv       Date:  2020-09-22

Review 2.  Venous thromboembolism in pediatric nephrotic syndrome.

Authors:  Bryce A Kerlin; Kellie Haworth; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2013-06-28       Impact factor: 3.714

3.  Deep Venous Reconstruction: A Case Series.

Authors:  Sebastian Kosasih; Hayley Moore; Tristan R Lane; Alun H Davies
Journal:  Cureus       Date:  2017-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.